NCT02396966View on ClinicalTrials.gov

Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Acromegaly
Trial Locations (18)

Unknown

Bialystok

Bydgoszcz

Bytom

Gdansk

Gliwice

Katowice

Kielce

Krakow

Lodz

Lublin

Olsztyn

Opole

Poznan

Rybnik

Rzeszów

Szczecin

Warsaw

Wroclaw

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT02396966 - Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. | Biotech Hunter | Biotech Hunter